Skip to content

Fostering Diversity & Inclusion: Embracing Differences at Scailyte

Highlighting Our Commitment to Diversity & Inclusion

A Diverse and Inclusive Team: Celebrating Differences at Scailyte

Highlighting Our Commitment to Diversity and Inclusion

🌍 At Scailyte, we take great pride in our commitment to Environmental, Social, and Governance (ESG) principles. Today, we want to highlight our strong focus on Diversity and Inclusion, particularly in terms of nationality and gender pay. 🌈🤝

With a team of 22 people, we have fostered a diverse and inclusive environment where everyone’s unique backgrounds and perspectives are celebrated. We firmly believe that diversity fuels innovation and drives success. 💡🚀

Gender diversity is a top priority for us, and we are proud to say that 50% of our full team consists of talented and inspiring women. But it doesn’t stop there—when it comes to leadership positions, 2 of the 3 C-level positions are held by exceptional women. 💼👩‍💼

Our diversity extends beyond gender. We are a team comprised of individuals from various nationalities, representing the rich tapestry of cultures around the globe. 🌎✨ Here is a snapshot of the nationalities that make up our Scailyte family:

🇧🇬 Bulgaria

🇨🇭 Switzerland

🇺🇸 USA

🇫🇷 France

🇮🇹 Italy

🇵🇹 Portugal

🇵🇱 Poland

🇩🇪 Germany

🇵🇰 Pakistan

🇮🇳 India

🇧🇩 Bangladesh

🏴󠁧󠁢󠁷󠁬󠁳󠁿 Wales

🇳🇿 New Zealand

🇭🇷 Croatia

By embracing such a diverse range of backgrounds, experiences, and perspectives, we foster an inclusive environment that values and respects everyone’s contributions. Together, we push the boundaries of innovation and create groundbreaking solutions for the future. 💪💫

At Scailyte, we firmly believe that true success is achieved through the collective power of a diverse and inclusive workforce. We remain committed to nurturing a culture that promotes equality, fosters innovation, and empowers every individual to thrive. 🌟🤝

 

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

Recent News

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

Recent News

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Recent News

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Recent News

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News

01 /04

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

02 /04

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

03 /04

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

04 /04

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News